On Friday, October 31st, AbbVie Inc. (ABBV) announced that its Board of Directors approved a quarterly dividend increase from $1.64 to $1.73 per share. The dividend is payable on February 17, 2026, to shareholders of record as of January 16, 2026. This marks a 5.49% increase over the previous quarterly dividend.
At the current price of $211.96 (yesterday's close), this increase will raise ABBV's dividend yield to 3.26%.
AbbVie is a Dividend Contenders with a 13 year streak of dividend increases. Dividend growth rates for 1, 3, 5 and 10 years are 4.7, 6.0, 7.7 and 14.1 (Dividend Champions.xls)
As an owner of 80 shares of ABBV, the recent dividend increase adds $21.46 to my projected annual net dividend income.
I was expecting a dividend increase of around 5%, so this announcement aligns perfectly with my expectations. It’s always nice to see AbbVie continue its strong track record of rewarding shareholders with consistent dividend growth.
This marks the eleventh dividend increase I’ve received from AbbVie since initiating my position in October 2016. Over that time, the company’s quarterly dividend has grown impressively from $0.57 to $1.73 per share — a cumulative increase of 203.5%. AbbVie continues to demonstrate its commitment to delivering strong and reliable income growth for shareholders.
As of this writing, AbbVie represents approximately 2.0% of my portfolio by weight and contributes around 1.53% to my projected annual dividend income.
Following this increase, my yield on cost is 10.09%.
Summary of 2025 Dividend Increases / Cuts
Click here to see my portfolio holdings.
You can follow the development of my dividends here.
Full Disclosure: Long ABBV
Thanks for stopping by!
No comments:
Post a Comment